166 related articles for article (PubMed ID: 7958719)
1. Inhibitory effect of vapiprost on contractile responses of isolated dog renal arteries to thromboxane A2 analogue, U46619.
Sakanashi M; Matsuzaki T; Noguchi K; Nakasone J; Itomine T; Uza M; Toyama F; Higuchi M
Gen Pharmacol; 1994 Jul; 25(4):617-22. PubMed ID: 7958719
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
[TBL] [Abstract][Full Text] [Related]
3. Regional vascular responses to thromboxane A2 analogue and their blockade with vapiprost, a selective thromboxane receptor blocking drug, in anesthetized dogs.
Noguchi K; Ojiri Y; Chibana T; Matsuzaki T; Sakanashi M
Jpn J Pharmacol; 1992 Dec; 60(4):341-8. PubMed ID: 1287269
[TBL] [Abstract][Full Text] [Related]
4. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery.
He GW; Yang CQ
J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery constriction by the isoprostane 8-epi prostaglandin F2 alpha.
Kromer BM; Tippins JR
Br J Pharmacol; 1996 Nov; 119(6):1276-80. PubMed ID: 8937734
[TBL] [Abstract][Full Text] [Related]
6. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
Lydford SJ; McKechnie KC; Dougall IG
Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
[TBL] [Abstract][Full Text] [Related]
8. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
[TBL] [Abstract][Full Text] [Related]
9. Modulation by adenosine of thromboxane A2 receptor-mediated constriction in the human umbilical artery.
Di Grande A; Malatino LS; Boura AL; Read MA; Walters WA
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):344-6. PubMed ID: 7952795
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
Ohkubo S; Nakahata N; Ohizumi Y
Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
[TBL] [Abstract][Full Text] [Related]
11. The contractile mechanism of beraprost sodium, a stable prostacyclin analog, in the isolated canine femoral vein.
Ishikawa M; Namiki A
Heart Vessels; 1994; 9(1):14-8. PubMed ID: 8113153
[TBL] [Abstract][Full Text] [Related]
12. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
[TBL] [Abstract][Full Text] [Related]
13. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.
Beasley RC; Featherstone RL; Church MK; Rafferty P; Varley JG; Harris A; Robinson C; Holgate ST
J Appl Physiol (1985); 1989 Apr; 66(4):1685-93. PubMed ID: 2525122
[TBL] [Abstract][Full Text] [Related]
14. Human internal mammary artery contraction by isoprostaglandin f(2alpha) type-III [8-iso-prostaglandin F(2alpha)].
Cracowski JL; Stanke-Labesque F; Devillier P; Chavanon O; Hunt M; Souvignet C; Bessard G
Eur J Pharmacol; 2000 May; 397(1):161-8. PubMed ID: 10844110
[TBL] [Abstract][Full Text] [Related]
15. Interspecies differences in thromboxane A2 receptors are distinguished by glibenclamide.
Kemp BK; McPherson GA
Eur J Pharmacol; 1998 Aug; 354(2-3):173-8. PubMed ID: 9754918
[TBL] [Abstract][Full Text] [Related]
16. Lack of endotoxin-induced hyporesponsiveness to U46619 in isolated neonatal porcine pulmonary but not mesenteric arteries.
Pérez-Vizcaíno F; Villamor E; Fernandez del Pozo B; Moro M; Tamargo J
J Vasc Res; 1996; 33(3):249-57. PubMed ID: 8924522
[TBL] [Abstract][Full Text] [Related]
17. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
18. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
19. Effects of a prostaglandin I2 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta.
Ozaki H; Abe A; Uehigashi Y; Kinoshita M; Hori M; Mitsui-Saito M; Karaki H
Jpn J Pharmacol; 1996 Jul; 71(3):231-7. PubMed ID: 8854205
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
